glp-1 prescription weight loss medications New Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity With FDA approval of Wegovy

, , , ,

Court of Appeals for the Tenth Circuit, 1995 Washington State Association for Justice President-Elect, 2025 2026 Executive Committee, Member Member, Amicus Committee, 2025 2026 Member, Nominations Committee, 2025 2026 Member, Legislative Steering Committee, 2025 2026 Eagle Member, 2006 Present Vice President, Legislative Affairs Committee 2023 2025 2nd Vice President Legislative Affairs, 2022 2023 Vice President, Public Affairs, 2020 2022 Member, Public Affairs, 2023 2025 Board of Governors At-Large, Member, 2019 2025 Washington State Trial Lawyers Association, 2000 2006 The National Trial Lawyers Top 100 Civil Plaintiff American Association for Justice, Member, 2017 Present Council of Presidents, 2025 2027 Foundation for Washington State Courts, Board Member Speaker, "Stronger Records, Stronger Outcomes: Documentation for PI Cases," GLP Attorneys Healthcare Provider Seminar , May 2026 Author, "2026 Legislative Passage of Reforms to Labor & Industries Medical Provider Network Will Increase Access to Care for Washingtons Injured Workers" Plexus (Washington State Chiropractic Association publication), April/May 2026 Speaker, "Maximizing Reimbursement & Managing Medical Liens," GLP Attorneys Healthcare Provider Seminar , February 2026 Co-Author, The Importance of Diversity in the Legal Profession, Washington State Association for Justice Trial News , December 2025 Featured, Committed to Justice, Community, and Mentorship: John Webber, WSAJs President-Elect, Washington State Association for Justice Trial News , October 2025 Author/Webinar Presenter, "Anatomy of a Trial," GLP Attorneys Healthcare Provider Seminar , October 2025 Author/Webinar Presenter, "Two Sides of L&I," GLP Attorneys Healthcare Provider Seminar , August 2025 Author/Webinar Presenter, "Insurance Bad Faith," GLP Attorneys Healthcare Provider Seminar , May 2025 Author/Webinar Presenter, "Insurance Tips & Tricks: Strategies for a New Era," GLP Attorneys Healthcare Provider Seminar , February 2025 Author/Webinar Presenter, "How a Personal Injury Case Ends: Two Paths to Resolution," GLP Attorneys Healthcare Provider Seminar , October 2024 Author/Webinar Presenter, "How a Personal Injury Case Progresses: The Treatment Phase," GLP Attorneys Healthcare Provider Seminar , August 2024 Author/Webinar Presenter, "How a Personal Injury Case Starts: The Critical First 90 Days," GLP Attorneys Healthcare Provider Seminar , May 2024 Author/Webinar Presenter, "Medical Liens," GLP Attorneys Healthcare Provider Seminar , February 2024 Author/Webinar Presenter, Mastering the MVC Injury, GLP Attorneys Healthcare Provider Seminar , October 2023 Author/Webinar Presenter, Mastering Insurance for Your Personal Injury Patient Practice, GLP Attorneys Healthcare Provider Seminar , August 2023 Author/Webinar Presenter, "Mastering Elements of a Personal Injury Patient Practice," GLP Attorneys Healthcare Provider Seminar , May 2023 Author/Webinar Presenter, "Mastering IMEs and Apportionments," GLP Attorneys Healthcare Provider Seminar , February 2023 "Why Medical Liens Are an Important Tool for Your Clinic's Personal Injury Practice," Plexus (Washington State Chiropractic Association publication), February/March 2023 Working for the Common Good, Plexus (Washington State Chiropractic Association publication), October/November 2013 Balancing Your Practice: Personal Injury Patients & Getting Paid in Full, Washington State Chiropractic Association Plexus , 2012 Related Video Practice Areas Related Successful Cases $500,000 Premises Liability $500,000 for a man who slipped on grease while on the job as a sanitation worker, falling into a hole in a poorly maintained parking lot, requiring shoulder surgery

GLP-2(Tirz): Where the Dual-Receptor Hypothesis Pays Off GLP-2(Tirz) is where the receptor-stacking research gets interesting

BioXconomy recently reported on a landmark study that showed GLP-1s cut mortality and hospitalization rates from heart failure by 40%, potentially independent of their weight loss effects

Defendants ignored the association between the use of GLP-1 receptor agonists and the risk of developing severe gastrointestinal issues, including gastroparesis and gastroenteritis, the lawsuit states

Noom program features comparison (2026) Each Noom program supports sustainable weight loss, but they differ in the type of support they offer